lorlatinib will lessen the extent or influence of ergotamine by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Steer clear of or Use Alternate Drug. Stay clear of use of lorlatinib with CYP3A substrates, where by minimum focus modifications may perhaps produce severe therapeutic failures with the substrate.Ergotism manifested by intensive a… Read More